| 000 | 00916 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250511183335.0 | ||
| 264 | 0 | _c19921026 | |
| 008 | 199210s 0 0 eng d | ||
| 022 | _a0361-8609 | ||
| 024 | 7 |
_a10.1002/ajh.2830410219 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aConrad, M E | |
| 245 | 0 | 0 |
_aCytarabine and cardiac failure. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _cOct 1992 |
||
| 300 |
_a143-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCytarabine _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 41 _gno. 2 _gp. 143-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.2830410219 _zAvailable from publisher's website |
| 999 |
_c1421671 _d1421671 |
||